Germany’s Merck to Buy U.K. Biotech Silence Therapeutics for $1.3 Billion Merck said it is offering $20 in cash for each American depositary share for Nasdaq-listed Silence Therapeutics, more than double the target’s closing price as of Friday. Post navigation Previous Previous post: Dainese Isn’t Gatekeeping Its Airbag Tech. That’s A Huge Win For RidersNext Next post: Jamie Dimon Tells Leaders to Ramp Up Cyber Defenses Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Save $570 on the ACEMAGIC M1A PRO+ (2TB+128G) or $360 on the M5 (512G+24G) mini PC’s 0 5 Mini Power Tools Under $50 Worth Adding To Your Collection 0
